# Ground Truth Medical Form (GTMF)

## Patient Information

- **Subject ID**: 695
- **Admission ID**: 154201
- **Row ID**: 10671
- **Profile Type**: FULL

## Demographics

- **Age**: 83
- **Sex**: F
- **Date of Birth**: 2093-05-14
- **Ethnicity**: UNKNOWN/NOT SPECIFIED
- **Marital Status**: MARRIED
- **Religion**: CATHOLIC
- **Insurance**: Medicare
- **Admission Type**: URGENT
- **Admission Date**: 2176-07-07 17:01:00
- **Discharge Date**: 2176-07-21 10:46:00

## Chief Complaint

abdominal pain and fever

## Symptoms

- **abdominal pain** | duration: long-standing
- **fever** | duration: intermittent

## Current Medications

- **vancomycin** | purpose: treatment of pseudocyst infection
- **levofloxacin** | purpose: treatment of pseudocyst infection
- **clindamycin** | purpose: treatment of pseudocyst infection
- **total parenteral nutrition** | purpose: nutritional support

## Discharge Medications

- **home blood pressure medications**
- **Propanolol** | dosage: 80 mg | frequency: p.o. t.i.d.
- **Diovan** | dosage: 80 mg | frequency: p.o. q.d.
- **Chlorothiazide** | dosage: 500 mg | frequency: p.o. q.d.
- **Protonix** | dosage: 40 mg | frequency: p.o. q.d.
- **Total parenteral nutrition**

## Diagnoses

- **alcohol related pancreatitis** | notes: long-standing
- **pancreatic pseudocyst** | notes: recurrent collection; confirmed by CT scan
- **pancreatic pseudocyst infection (Staphylococcus non-aureus)** | notes: cyst fluid culture positive

## Treatment Options

### percutaneous pseudocyst drainage

**Details**: initial drainage on 2176-6-24; repeat drain placed on 2176-7-10 after unsuccessful attempt on 2176-7-8

### antibiotic therapy

**Details**: vancomycin, levofloxacin, clindamycin for pseudocyst infection

**Medications**:
- vancomycin (not provided)
- levofloxacin (not provided)
- clindamycin (not provided)

### nutritional support

**Details**: total parenteral nutrition continued; advanced from clear to low fat diet

### Total parenteral nutrition

**Details**: Patient was on total parenteral nutrition and tolerating p.o. intake.
